(DBXJ) MSCI Japan - Overview
Etf: Equity, Japan, ETF, Fund
| Risk 5d forecast | |
|---|---|
| Volatility | 17.8% |
| Relative Tail Risk | -4.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.79 |
| Alpha | 12.67 |
| Character TTM | |
|---|---|
| Beta | 0.215 |
| Beta Downside | 0.493 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.96% |
| CAGR/Max DD | 0.97 |
Description: DBXJ MSCI Japan January 15, 2026
The Xtrackers MSCI Japan UCITS ETF (ticker DBXJ) tracks the Morningstar Japan Total Market Index (TME) net-return, denominated in JPY. It is a German-domiciled exchange-traded fund that provides exposure to large-cap Japanese equities across a blended (growth/value) style.
Key fund metrics (as of the most recent public filing) include an expense ratio of roughly 0.20 % and assets under management of about €1.2 bn, placing it among the more liquid Japan-focused ETFs. The top ten holdings are heavily weighted toward the technology and automotive sectors, with companies such as Toyota, Sony and Keyence accounting for roughly 30 % of the portfolio.
From a macro perspective, the ETF’s performance is closely tied to two primary drivers: (1) the trajectory of the Japanese yen, which has depreciated about 12 % against the USD over the past 12 months, boosting export-oriented earnings; and (2) the Bank of Japan’s monetary stance, where any shift away from ultra-loose policy could materially affect equity valuations. Current estimates suggest Japan’s real GDP growth will hover near 1 % YoY in 2024, providing modest tailwinds for domestic consumption-driven firms.
Given the fund’s blend of sector exposure and currency risk, a deeper dive into its turnover rate and sector-specific beta could clarify its risk-adjusted return profile-information you can explore further on ValueRay.
What is the price of DBXJ shares?
Over the past week, the price has changed by +4.47%, over one month by +6.41%, over three months by +9.31% and over the past year by +18.30%.
Is DBXJ a buy, sell or hold?
What are the forecasts/targets for the DBXJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 106.9 | 13.5% |
DBXJ Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.76b EUR (1.76b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.76b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.76b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.71% (E(1.76b)/V(1.76b) * Re(6.71%) + (debt-free company))
Discount Rate = 6.71% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)